# Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens.

> PubMed lists PMID 23039898 in The American journal of managed care as Comparative Study, Journal Article, with publication-date metadata of 2012-09 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23039898-exenatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23039898-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-23039898-exenatide-v1.json
- Content SHA-256: `d2be2b0bbb7680a8e26936f34477f19ff646a2152d1d4a4854cd50b374adb8ed`

## Claims and source pins

### Headline

Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. ([`pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0`](#source-pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0))

### Summary

PubMed lists PMID 23039898 in The American journal of managed care as Comparative Study, Journal Article, with publication-date metadata of 2012-09 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0`](#source-pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0))

### Paragraph 1

PubMed lists PMID 23039898 in The American journal of managed care as Comparative Study, Journal Article, with publication-date metadata of 2012-09 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0`](#source-pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0`](#source-pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0))

## Sources

<a id="source-pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0"></a>
- **Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. · retained source version 1:2026-01-28:current:43ea9aa337d09491cbb0dfc2ecce0ce50228a7f93515d35fd46369af867726dd** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23039898/) (`pubmed-observation-pmid-23039898-2026-01-28-43ea9aa337d0`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-23039898-exenatide-v1.json SHA-256: d2be2b0bbb7680a8e26936f34477f19ff646a2152d1d4a4854cd50b374adb8ed.